Home injection study shows promise for myasthenia gravis patients
NCT ID NCT05681715
First seen Nov 06, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looked at whether 62 adults with generalized myasthenia gravis could safely give themselves the drug rozanolixizumab at home after training. Participants used either a syringe driver or manual push method. The main goal was to see if they could correctly choose the injection site, give the shot under the skin, and deliver the full dose. The study also tracked any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mg0020 20068
Chiba, Japan
-
Mg0020 20076
Shinjuku-ku, Japan
-
Mg0020 20077
Sendai, Japan
-
Mg0020 20078
Hanamaki-shi, Japan
-
Mg0020 20161
Tbilisi, Georgia
-
Mg0020 20165
Tbilisi, Georgia
-
Mg0020 20305
Tbilisi, Georgia
-
Mg0020 40140
Göttingen, Germany
-
Mg0020 40144
Milan, Italy
-
Mg0020 40146
Pavia, Italy
-
Mg0020 40150
Roma, Italy
-
Mg0020 40153
Poznan, Poland
-
Mg0020 40155
Gdansk, Poland
-
Mg0020 40160
Barcelona, Spain
-
Mg0020 40163
Oxford, United Kingdom
-
Mg0020 40168
Nottingham, United Kingdom
-
Mg0020 40177
Münster, Germany
-
Mg0020 40267
Barcelona, Spain
-
Mg0020 40308
San Sebastián de los Reyes, Spain
-
Mg0020 40727
Lodz, Poland
-
Mg0020 40729
Niš, Serbia
-
Mg0020 50069
Toronto, Canada
-
Mg0020 50090
Winston-Salem, North Carolina, 27157, United States
-
Mg0020 50092
Orange, California, 92868, United States
-
Mg0020 50099
San Francisco, California, 94143, United States
-
Mg0020 50560
Edmonton, Canada
-
Mg0020 50561
Lexington, Kentucky, 40536-0284, United States
Conditions
Explore the condition pages connected to this study.